Impact of an Early Prostate-Specific Antigen Response on Biochemical Progression during Upfront Androgen Receptor Signal Inhibitor Therapy for Metastatic Hormone-Sensitive Prostate Cancer
An early PSA response within 3 months of ARSI initiation was associated with PSA progression in patients with mHSPC.
Authors
- Kiyoshi Setoguchi (ORCID: https://orcid.org/0000-0003-2298-7478)
- Kazutaka Saito (ORCID: https://orcid.org/0000-0002-7261-0188)
- Hiroki Tsujioka (ORCID: https://orcid.org/0000-0002-5943-0641)
- Asumi Nirazuka
- Minoru Inoue (ORCID: https://orcid.org/0000-0002-6312-6757)
- Keita Izumi (ORCID: https://orcid.org/0000-0002-9785-6432)
- Akinori Nakayama
- Gaku Arai
Institutions
- Social Insurance Saitama Chuo Hospital (JP)
- Dokkyo Medical University (JP)
Publication Details
- Journal
- Urologia Internationalis
- Published
- 2025-05-22
- DOI
- https://doi.org/10.1159/000546327
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00